Critically analyse timeline slippages and cost escalation in India's major space megaprojects, with reference to Gaganyaan.

Gaganyaan, sanctioned in 2019 at ₹9,023 crore to demonstrate human spaceflight to Low Earth Orbit and safe return [2], now carries a revised outlay of ₹20,193 crore [3] with the crewed flight still ahead. It illustrates both the ambition and the delivery risk in India's space megaprojects.

Extent of timeline slippage

• Ministerial statements once placed the maiden human flight around 2023 [6]; the programme was described as entering its "final phase" only in 2025 [5], with uncrewed missions G1–G3 and the crewed flight pushed further [1].
• The TV-D1 abort test flew in October 2023 [4], years after sanction — critical-path qualification bunched late.

Cost escalation

• Net additional funding of ₹11,170 crore took the outlay to ₹20,193 crore [3].
• Much of this is scope-driven, not pure overrun: the Cabinet extended the programme to eight missions and the first module of the Bharatiya Antariksh Station by December 2028 [3].
• Residual causes: pandemic disruption and first-time indigenisation of life-support, thermal protection and Crew Escape System hardware [1].

Critical assessment

• Defensible: human-rating is safety-critical; crew lives outrank deadlines. Sequential qualification — five CES motor types static tested, HLVM3 ground-tested, TV-D1 flown — is prudent engineering [1][4].
• Durable assets: Gaganyaan Control Centre, Orbital Module Preparation Facility, Crew Training Facility and second launch pad modifications are reusable national capital [1].
• Problematic: announcement-first deadlines fixed before design freeze erode credibility; repeated revisions weaken financial oversight and defer commercial spin-offs within a modest space budget.

Slippage in Gaganyaan reflects the frontier character of human spaceflight more than administrative failure, yet the habit of optimistic target-setting needs correction. Milestone-linked budgeting at sanction, independent design reviews, and deeper private participation through IN-SPACe can compress future timelines. Judged by capability built rather than dates missed, Gaganyaan remains a sound investment in India's strategic and scientific self-reliance.